Fatigue and quality of life in patients with neuroendocrine neoplasia

References

• Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–1342.
   PubMed Web of Science ®Google Scholar
• Oronsky B, Ma PC, Morgensztern D, et al. Nothing But NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991–1002.
   PubMed Web of Science ®Google Scholar
• O'Toole D, Kianmanesh R, Caplin M. ENETS 2016 consensus guidelines for the management of patients with digestive neuroendocrine tumors: an update. Neuroendocrinology. 2016;103(2):117–118.
   PubMed Web of Science ®Google Scholar
• Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP. Carcinoid syndrome: update on the pathophysiology and treatment. Clinics. 2018;73(suppl 1):e490s.
   PubMedGoogle Scholar
• Caplin ME, Baudin E, Ferolla P, ENETS Consensus Conference Participants, et al. Pulmonary neuroendocrine (carcinoid) tumors: European neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol. 2015;26(8):1604–1620.
   PubMed Web of Science ®Google Scholar
• Janson ET, Sørbye H, Welin S, et al. Nordic guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol. 2010;49(6):740–756.
   PubMed Web of Science ®Google Scholar
• Pommergaard HC, Nielsen K, Sorbye H, et al. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms. J Neuroendocrinol. 2021;33(5):e12967.
   PubMed Web of Science ®Google Scholar
• Delle Fave G, O'Toole D, Sundin A, Vienna Consensus Conference participants, et al. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms. Neuroendocrinology. 2016;103(2):119–124.
   PubMed Web of Science ®Google Scholar
• Garcia-Carbonero R, Sorbye H, Baudin E, Vienna Consensus Conference participants, et al. ENETS consensus guidelines for High-Grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103(2):186–194.
   PubMed Web of Science ®Google Scholar
• Boyar Cetinkaya R, Aagnes B, Myklebust TÅ, et al. Survival in neuroendocrine neoplasms; a report from a large norwegian population-based study. Int J Cancer. 2018;142(6):1139–1147.
   PubMed Web of Science ®Google Scholar
• Korse CM, Taal BG, van Velthuysen ML, et al. Incidence and survival of neuroendocrine tumours in The Netherlands according to histological grade: experience of two decades of cancer registry. Eur J Cancer. 2013;49(8):1975–1983.
   PubMed Web of Science ®Google Scholar
• Boini S, Briançon S, Guillemin F, et al. Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment. Health Qual Life Outcomes. 2004;2:4.
   PubMedGoogle Scholar
• Bower JE. Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609.
   PubMed Web of Science ®Google Scholar
• Wang XS, Woodruff JF. Cancer-related and treatment-related fatigue. Gynecol Oncol. 2015;136(3):446–452.
   PubMed Web of Science ®Google Scholar
• Cotogni P, De Carli L, Passera R, et al. Longitudinal study of quality of life in advanced cancer patients on home parenteral nutrition. Cancer Med. 2017;6(7):1799–1806.
   PubMed Web of Science ®Google Scholar
• Bui AT, Yong Ji KS, Pham CT, et al. Longitudinal evaluation of quality of life in laryngeal cancer patients treated with surgery. Int J Surg. 2018;58:65–70.
   PubMed Web of Science ®Google Scholar
• Jiménez-Fonseca P, Carmona-Bayonas A, Martín-Pérez E, Spanish Neuroendocrine Tumor Group (GETNE), et al. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev. 2015;34(3):381–400.
   PubMed Web of Science ®Google Scholar
• Watson C, Tallentire CW, Ramage JK, et al. Quality of life in patients with gastroenteropancreatic tumours: a systematic literature review. World J Gastroenterol. 2020;26(25):3686–3711.
   PubMed Web of Science ®Google Scholar
• Adams JR, Ray D, Willmon R, et al. Living with neuroendocrine tumors: assessment of quality of life through a mobile application. J Clin Oncol Clin Cancer Inform. 2019;3(3):1–10.
   Google Scholar
• Strosberg J, Wolin E, Chasen B, NETTER-1 Study Group, et al. Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with (177)Lu-Dotatate in the phase III NETTER-1 trial. J Clin Oncol. 2018;36(25):2578–2584.
   PubMed Web of Science ®Google Scholar
• Pearman TP, Beaumont JL, Cella D, et al. Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden. Support Care Cancer. 2016;24(9):3695–3703.
   PubMed Web of Science ®Google Scholar
• Gosain R, Gupta M, Roy AM, et al. Health-related quality of life (HRQoL) in neuroendocrine tumors: a systematic review. Cancers. 2022;14(6):1428.
   PubMed Web of Science ®Google Scholar
• Haugland T, Vatn MH, Veenstra M, et al. Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population. Qual Life Res. 2009;18(6):719–726.
   PubMed Web of Science ®Google Scholar
• Haugland T, DeVon HA. Symptoms, psychosocial factors, and health-related quality of life in patients with neuroendocrine tumors: an integrative review. Cancer Nurs. 2019;42(4):E36–e46.
   PubMed Web of Science ®Google Scholar
• Kulke MH, Hörsch D, Caplin ME, et al. Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome. J Clin Oncol. 2017;35(1):14–23.
   PubMed Web of Science ®Google Scholar
• Cella D, Beaumont JL, Hudgens S, et al. Relationship between symptoms and health-related quality-of-life benefits in patients with carcinoid syndrome: post hoc analyses from TELESTAR. Clin Ther. 2018;40(12):2006–2020.e2.
   PubMed Web of Science ®Google Scholar
• Martini C, Gamper EM, Wintner L, et al. Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours. Health Qual Life Outcomes. 2016;14(1):127.
   PubMedGoogle Scholar
• Beaumont JL, Cella D, Phan AT, et al. Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population. Pancreas. 2012;41(3):461–466.
   PubMed Web of Science ®Google Scholar
• Group TE. EuroQol-a new facility for the measurement of health-related quality of life. 1990;16(3):199–208.
   Google Scholar
• Sørensen J, Davidsen M, Gudex C, et al. Danish EQ-5D population norms. Scand J Public Health. 2009;37(5):467–474.
   PubMed Web of Science ®Google Scholar
• Oppe M, Rand-Hendriksen K, Shah K, et al. EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics. 2016;34(10):993–1004.
   PubMed Web of Science ®Google Scholar
• Bravo Vergel Y, Sculpher M. Quality-adjusted life years. Pract Neurol. 2008;8(3):175–182.
   PubMedGoogle Scholar
• Smets EMA, Garssen B, Bonke B, et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. JPsychosomRes. 1995;39(3):315–325.
   PubMed Web of Science ®Google Scholar
• Schwarz R, Krauss O, Hinz A. Fatigue in the general population. Onkologie. 2003;26(2):140–144.
   PubMedGoogle Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
   PubMed Web of Science ®Google Scholar
• Yadegarfar G, Friend L, Jones L, on behalf of the EORTC Quality of Life Group, et al. Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. Br J Cancer. 2013;108(2):301–310.
   PubMed Web of Science ®Google Scholar
• Fröjd C, Larsson G, Lampic C, et al. Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study. Health Qual Life Outcomes. 2007;5:18.
   PubMed Web of Science ®Google Scholar
• Wolin EM, Benson Iii AB. Systemic treatment options for carcinoid syndrome: a systematic review. Oncology. 2019;96(6):273–289.
   PubMed Web of Science ®Google Scholar
• Lawrence DP, Kupelnick B, Miller K, et al. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;2004(32):40–50.
   Google Scholar
• Sorbye H, Meyer LS, Mordal KE, et al. Patient reported symptoms, coping and quality of life during somatostatin analogue treatment for metastatic small- intestinal neuroendocrine tumours. Health Qual Life Outcomes. 2020;18(1):188.
   PubMed Web of Science ®Google Scholar
• Corbett TK, Groarke A, Devane D, et al. The effectiveness of psychological interventions for fatigue in cancer survivors: systematic review of randomised controlled trials. Syst Rev. 2019;8(1):324.
   PubMed Web of Science ®Google Scholar
• Lerdal A, Wahl A, Rustøen T, et al. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health. 2005;33(2):123–130.
   PubMed Web of Science ®Google Scholar
• Spolverato G, Bagante F, Wagner D, et al. Quality of life after treatment of neuroendocrine liver metastasis. J Surg Res. 2015;198(1):155–164.
   PubMed Web of Science ®Google Scholar
• Harms CA, Cohen L, Pooley JA, et al. Quality of life and psychological distress in cancer survivors: the role of psycho-social resources for resilience. Psychooncology. 2019;28(2):271–277.
   PubMed Web of Science ®Google Scholar
• Haugland T, Wahl AK, Hofoss D, et al. Association between general self-efficacy, social support, cancer-related stress and physical health-related quality of life: a path model study in patients with neuroendocrine tumors. Health Qual Life Outcomes. 2016;14:11.
   PubMed Web of Science ®Google Scholar
• Karppinen N, Lindén R, Sintonen H, et al. Health-related quality of life in patients with small intestine neuroendocrine tumors. Neuroendocrinology. 2018;107(4):366–374.
   PubMed Web of Science ®Google Scholar
• Green CA, Pope CR. Gender, psychosocial factors and the use of medical services: a longitudinal analysis. Soc Sci Med. 1999;48(10):1363–1372.
   PubMed Web of Science ®Google Scholar